Format

Send to

Choose Destination
Kidney Int. 2008 Aug;74(3):300-9. doi: 10.1038/ki.2008.179. Epub 2008 May 14.

Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury.

Author information

1
Nephro-Urology Unit, University College London, Institute of Child Health, London, UK. d.long@ich.ucl.ac.uk

Abstract

The loss of interstitial capillaries is a feature of several experimental models of renal disease and this contributes to secondary kidney injury. Angiopoietin-1 is a secreted growth factor which binds to Tie-2 present on endothelia to enhance cell survival thereby stabilizing capillary architecture in-vitro. Previous studies showed that angiopoietin-1 prevented renal capillary and interstitial lesions following experimental ureteric obstruction. We tested here the effect of angiopoietin-1 treatment on capillary loss and associated tubulointerstitial damage known to follow recovery from folic acid-induced tubular necrosis and acute renal injury. We found that delivery of angiopoietin-1 by adenoviral vectors stabilized peritubular capillaries in folic acid nephropathy but this was accompanied by profibrotic and inflammatory effects. These results suggest that the use of endothelial growth factor therapy for kidney disease may have varying outcomes that depend on the disease model tested.

PMID:
18480750
DOI:
10.1038/ki.2008.179
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center